Table 4 Main findings (secondary outcomes).
Angina | Heart failure | Diabetes incidence | |
|---|---|---|---|
Diuretics vs. BB | 0.96 (0.28 to 5.78) | 0.73 (0.54 to 0.96) | 1.09 (0.80 to 1.44) |
⊕ OOO | ⊕ ⊕ ⊕ O | ⊕ ⊕ OO | |
Diuretics vs. ACE | 0.97 (0.42 to 2.51) | 0.88 (0.76 to 1.06) | 1.43 (1.12 to 1.83) |
⊕ ⊕ OO | ⊕ ⊕ OO | ⊕ ⊕ ⊕ O | |
Diuretics vs. CCB | 1.05 (0.56 to 2.19) | 0.73 (0.62 to 0.84) | 1.27 (1.05 to 1.57) |
⊕ ⊕ OO | ⊕ ⊕ ⊕ O | ⊕ ⊕ ⊕ ⊕ | |
Diuretics vs. alpha-blockers | 0.89 (0.31 to 2.52) | 0.51 (0.40 to 0.64) | - |
⊕ OOO | ⊕ ⊕ ⊕ O | ||
Diuretics vs. ARB | 0.86 (0.39 to 3.27) | 0.80 (0.61 to 0.98) | 1.59 (1.23 to 2.12) |
⊕ OOO | ⊕ ⊕ OO | ⊕ ⊕ OO | |
BB vs. ACE | 1.03 (0.17 to 3.76) | 1.21 (0.91 to 1.69) | 1.31 (0.95 to 1.88) |
⊕ OOO | ⊕ OOO | ⊕ OOO | |
BB vs. CCB | 1.10 (0.23 to 3.31) | 1.00 (0.76 to 1.33) | 1.17 (0.89 to 1.61) |
⊕ OOO | ⊕ OOO | ⊕ OOO | |
BB vs. alpha-blockers | 0.93 (0.11 to 4.35) | 0.69 (0.50 to 1.02) | - |
⊕ OOO | ⊕ OOO | ||
BB vs. ARB | 0.88 (0.31 to 2.58) | 1.08 (0.86 to 1.38) | 1.46 (1.15 to 1.98) |
⊕ ⊕ OO | ⊕ ⊕ ⊕ ⊕ | ⊕ ⊕ ⊕ ⊕ | |
ACE vs. CCB | 1.08 (0.48 to 2.44) | 0.82 (0.69 to 0.94) | 0.89 (0.73 to 1.10) |
⊕ OOO | ⊕ ⊕ ⊕ O | ⊕ ⊕ OO | |
ACE vs. alpha-blockers | 0.91 (0.22 to 3.42) | 0.58 (0.43 to 0.75) | - |
⊕ OOO | ⊕ ⊕ OO | ||
ACE vs. ARB | 0.86 (0.35 to 3.50) | 0.90 (0.67 to 1.10) | 1.11 (0.85 to 1.51) |
⊕ OOO | ⊕ OOO | ⊕ OOO | |
CCB vs. alpha-blockers | 0.85 (0.23 to 2.78) | 0.70 (0.53 to 0.92) | - |
⊕ OOO | ⊕ ⊕ OO | ||
CCB vs. ARB | 0.81 (0.45 to 2.30) | 1.10 (0.87 to 1.31) | 1.25 (1.02 to 1.56) |
⊕ ⊕ OO | ⊕ ⊕ ⊕ O | ⊕ ⊕ ⊕ ⊕ | |
Alpha-blockers vs. ARB | 0.95 (0.29 to 5.71) | 1.57 (1.09 to 2.12) | - |
⊕ OOO | ⊕ ⊕ OO |